Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"
NCT02003014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 899
Last updated 2016-11-10
Summary
To investigate the safety and efficacy of long-term treatment with pioglitazone (Actos tablets) in combination with biguanides (for 12 months after the start of pioglitazone tablets treatment) in patients with type 2 diabetes mellitus.
Conditions
Interventions
- DRUG
-
Pioglitazone
Pioglitazone Tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Postmarketing Group Manager · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
More Related Trials
-
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
NCT00395512 ·Status: COMPLETED ·Phase: PHASE3
-
Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
NCT01990300 ·Status: COMPLETED
-
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
NCT00328627 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
NCT02024971 ·Status: COMPLETED
-
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00432276 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients
NCT01225081 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
NCT00772174 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
NCT00232362 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00286494 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
NCT00500331 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
NCT02753803 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
NCT00727857 ·Status: COMPLETED ·Phase: PHASE3
-
Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
NCT00649012 ·Status: COMPLETED ·Phase: PHASE1
-
Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
NCT00086502 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
NCT02697617 ·Status: COMPLETED ·Phase: PHASE2
-
Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
NCT00649558 ·Status: COMPLETED ·Phase: PHASE1
-
The Practical Evidence of Antidiabetic Combination Therapy in Korea
NCT02231021 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
NCT02175784 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
NCT01799850 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Albiglutide in Type 2 Diabetes
NCT00849056 ·Status: COMPLETED ·Phase: PHASE3
-
Pioglitazone in Thyroid Cancers
NCT01655719 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
NCT02678676 ·Status: COMPLETED
-
Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
NCT00575874 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
NCT06571591 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
NCT00419484 ·Status: COMPLETED